Risk Factors for Primary Angle-closure Glaucoma: A Systematic Review and Meta-Analysis of 45 Studies

Y Wang, XX Dong, XW Hou… - Optometry and Vision …, 2023 - journals.lww.com
METHODS A systematic review and meta-analysis were conducted by searching the
electronic databases including PubMed, EMBASE, and Web of Science from their inception …

The efficacy of brimonidine in preventing intraocular pressure elevation in the provocative test for primary angle-closure glaucoma

YF Chen, PT Hung, JW Hsieh, J Shein… - Journal of ocular …, 2002 - liebertpub.com
The purpose of this study was to evaluate the efficacy of 0.2% brimonidine tartrate in
preventing intraocular pressure (IOP) elevation in the dark-prone provocative test for primary …

Oral imipramine and acute angle closure glaucoma

R Ritch, T Krupin, C Henry, F Kurata - Archives of Ophthalmology, 1994 - jamanetwork.com
Objective: To document acute angle closure glaucoma temporally related to ingestion of oral
imipramine hydrochloride. Patients: Four patients with narrow angles received routinely …

Treatment of the fellow eye in acute angle-closure glaucoma: A case report and survey of members of the American Glaucoma Society

JM Davidorf, ND Baker, R Derick - Journal of glaucoma, 1996 - journals.lww.com
Purpose: A survey of members of the American Glaucoma Society was compiled to
determine the treatment practices of subspecialty-trained glaucoma specialists regarding the …

Bilateral angle-closure glaucoma in a young female receiving cabergoline: a case report

H Razmjoo, L Rezaei, A Dehghani, A Peyman… - Case reports in …, 2011 - karger.com
Purpose: To report a case of bilateral acute angle-closure glaucoma after oral administration
of cabergoline for the treatment of galactorrhea. Methods: A diagnosis of secondary drug …

Identification and management of glaucoma

S Mamtora, D Leadbetter, D Atan - Prescriber, 2022 - Wiley Online Library
Glaucoma is the leading cause of irreversible blindness and the aim of all glaucoma
treatments is to lower intraocular pressure (IOP), the only modifiable risk factor. This article …

Chronic open-angle glaucoma. Review for primary care physicians.

FA Adatia, KF Damji - Canadian family physician, 2005 - cfp.ca
INTRODUCTION Chronic open-angle glaucoma (COAG) is a leading cause of irreversible
blindness worldwide, including in Canada. It presents a challenge in diagnosis, as disease …

Effect of beclomethasone nasal spray on intraocular pressure in ocular hypertension or controlled glaucoma

D Yuen, YM Buys, YP Jin, T Alasbali… - Journal of …, 2013 - journals.lww.com
Purpose To evaluate the effect of 6 weeks administration of beclomethasone nasal spray on
intraocular pressure (IOP) in patients with ocular hypertension or controlled primary open …

Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or …

J Michaud, B Friren… - American journal of …, 2001 - Elsevier
PURPOSE: The aim was to compare topical brinzolamide 1% twice daily with dorzolamide
2% twice daily, each given with timolol 0.5% twice daily, for safety and effects on intraocular …

The frequency of acute glaucoma crises. Implications for the detection of the risk of angle-closure

E Vadot, C Grateau - Bulletin des Societes D'ophtalmologie de …, 1989 - europepmc.org
Over a 5 year period 61 patients with acute angle closure glaucoma have been registered in
Department Savoie (323,675 inhabitants). The annual incidence is therefore 3, 8/100,000 …